SCHEMBL5233173

SCHEMBL5233173

N#Cc1cnn2c(Cl)c(-c3c(F)cccc3Cl)cnc12

nearest known ligand 0.48

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 7/20 0.48
ALDH1A1 P00352 6/20 0.48
LMNA P02545 2/20 0.48
POLB P06746 1/20 0.48
RXFP1 Q9HBX9 1/20 0.48
KDM4D Q6B0I6 1/20 0.44
HPGD P15428 1/20 0.40
CLK4 Q9HAZ1 1/20 0.40
TSHR P16473 1/20 0.39
TYK2 P29597 1/20 0.37
SMN1; SMN2 Q16637 2/20 0.36
GAA P10253 1/20 0.36
KDR P35968 1/20 0.36
GABRA1 P14867 2/20 0.36
GABRG2 P18507 2/20 0.36
GABRB3 P28472 2/20 0.36
GABRA5 P31644 2/20 0.36
GABRA3 P34903 2/20 0.36
GABRA2 P47869 1/20 0.36
HTT P42858 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5232778 0.82 KDM4E (0.40) KDM4EALDH1A1LMNAPOLBRXFP1
SCHEMBL4695582 0.81 CSNK2A1 (0.39) KDM4EALDH1A1LMNAPOLBRXFP1
SCHEMBL14257400 0.73 LMNA (0.40) KDM4EALDH1A1LMNAKDM4DHPGD
SCHEMBL14463715 0.72 ALDH1A1 (0.46) KDM4EALDH1A1LMNAKDM4DHPGD
SCHEMBL26621993 0.70 KDM4E (0.60) KDM4EALDH1A1LMNAPOLBRXFP1
SCHEMBL5230928 0.69 KDM4D (0.43) KDM4EALDH1A1LMNAPOLBRXFP1
SCHEMBL4708598 0.68 KDM4E (0.51) KDM4EALDH1A1LMNAPOLBRXFP1
SCHEMBL29071794 0.68 KDM4E (0.73) KDM4EALDH1A1LMNAPOLBRXFP1
SCHEMBL4693069 0.67 PDE2A (0.41) KDM4EALDH1A1LMNAHPGDTSHR
SCHEMBL14039397 0.67 KDM4E (0.53) KDM4EALDH1A1LMNAPOLBRXFP1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1513843-B1 PYRAZOLOPYRIMIDINES AND THE USE THEREOF FOR CONTROLLING HARMFUL ORGANISMS BAYER CROPSCIENCE AG (DE) 2007-07-04 EP disclosed
US-20060089499-A1 Pyrazolopyrimidines and the use thereof for controlling harmful organisms UWW VENTURES UNLIMITED (GB) 2006-04-27 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20060089499-A1 Pyrazolopyrimidines and the use thereof for controlling harmful organisms PRDX1, PRDX2, PRDX5 KDM4E 3455/4885ALDH1A1 907/4885LMNA 4335/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.